Systematic review / meta-analysis / 2017
Evidence is lacking for isocaloric ketogenic diet benefits in cancer patients
A systematic review evaluated clinical evidence on isocaloric ketogenic diets in cancer patients. Evidence supporting benefits on tumor development, progression, or cancer therapy side effects was missing. In addition, multiple potential adverse effects were noted, leading authors to state that robust clinical evidence is required before recommending this diet for cancer.
- Study type
- Systematic review
- Who was studied
- cancer patients across clinical studies
- What was measured
- tumor development, progression, and cancer therapy side effects
THE PAPER
Systematic review: isocaloric ketogenic dietary regimes for cancer patients.
Erickson N, Boscheri A, Linke B, Huebner J. Med Oncol, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.